$1.20
0.054.80%
Pre-Market: 9:27 AM EDT
15 minutes delayed
Clearside Biomedical reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Clearside Biomedical using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-12 | $-0.10 | $-0.13 | 23.1 % |
Mar 2024 | 2024-05-09 | $-0.17 | $-0.14 | -21.4 % |
Dec 2023 | 2024-03-12 | $-0.08 | $-0.09 | 11.1 % |
Sep 2023 | 2023-11-13 | $-0.15 | $-0.15 | 0.00 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-12 | $90.00K | $150.00K | -40.0 % |
Mar 2024 | 2024-05-09 | $230.00K | $580.00K | -60.3 % |
Dec 2023 | 2024-03-12 | $6.35M | $4.43M | 43.2 % |
Sep 2023 | 2023-11-13 | $859.00K | $160.00K | 436.9 % |
Clearside Biomedical (CLSD) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 12, 2024 for Q2.
The Actual EPS was $-0.10, which beat the estimate of $-0.13.
The Actual Revenue was $90K, which missed the estimate of $150K.
Browse earnings estimates, EPS, and revenue on all stocks.